News

Below is Validea's guru fundamental report for PALANTIR TECHNOLOGIES INC (PLTR). Of the 22 guru strategies we follow, PLTR rates highest using our Quantitative Momentum Investor model based on the ...
The serial Tesla road-rage driver who landed back behind bars for allegedly assaulting a teen driver and her mother in Hawaii last week was found beaten to a bloody pulp in prison. Nathaniel ...
Palantir Technologies Inc. (PLTR)’s offerings are “mission critical for” the defense of America, and Washington will not cut its spending on Palantir’s products, and services, said Kenny ...
Benzinga - Video PLTR Stock Remains Long-Term Buy Despite Sky-High Valuation, Says Prime Capital's McGough—Joins Dan Ives In Predicting Posted: May 13, 2025 | Last updated: May 13, 2025 Palantir ...
Benzinga PLTR Stock Remains Long-Term Buy Despite Sky-High Valuation, Says Prime Capital's McGough—Joins Dan Ives In Predicting $1 Trillion Market Cap Amid AI Surge Posted: May 13, 2025 | Last ...
Palantir Technologies has been one of the best-performing stocks in the S&P 500 and Nasdaq-100 over the last year. While enthusiasm over Palantir's AI opportunities have driven its stock to new ...
Palantir PLTR also expects at least 68% growth in U.S. commercial revenue, to upward of $1.178 billion. Previously, the company was targeting 54% growth there. Britney Nguyen is a tech reporter ...
Palantir Technologies Inc. PLTR remains a stock to hold for the long term despite recent market volatility, with the potential to reach a $1 trillion valuation, according to Will McGough ...
Cathie Wood’s Ark Invest has recently offloaded even more Palantir (NASDAQ:PLTR) after the recent post-earnings plunge. Ark still holds PLTR, but the selling action has been big enough to raise ...
Palantir could see another 18% upside. Helping, analysts at Wedbush just raised their price target to $140 from $120, noting that PLTR’s results and raised guidance give the firm “great ...
More information: Ziniu Yu et al, MicroRNA-27a transfected dental pulp stem cells undergo odonto/osteogenic differentiation via targeting DKK3 and SOSTDC1 in Wnt/BMP signaling in vitro and enhance ...